Flow Neuroscience

company

About

Flow Neuroscience is a healthcare company that develops direct current stimulation device and behavioral therapy app for depression.

  • 1 - 10

Details

Last Funding Type
Series A
Last Funding Money Raised
€8.50M
Industries
Health Care,Medical Device,Wearables
Founded date
Jan 1, 2016
Number Of Employee
1 - 10
Operating Status
Active

Flow Neuroscience is a healthcare company that develops depression treatment devices that combines an easy-to-use brain stimulation headset with a personalized mobile app to target both the physical and behavioral elements of Major Depressive Disorder (MDD). The company's wearable stimulates a patient's left frontal lobe, the area of the brain that has often lowered activity in people suffering from depression.

Flow Neuroscience combines their wearable with a mobile app that nudges users to behaviors that will help lessen the effects of their depression, including exercise and regular sleeping patterns.

The company's hope is to make available for the public a treatment that's currently only used in clinics specialized in brain stimulation. It also wants to make the treatment affordable enough to seriously challenge a dominant pharmaceuticals industry.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
3
€8.50M $1.10M
Flow Neuroscience has raised a total of €8.50M $1.10M in funding over 2 rounds. Their latest funding was raised on Aug 10, 2021 from a Series A round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Aug 10, 2021 Series A €8.50M 2 SwissHealth Ventures Detail
Dec 10, 2020 Convertable Note 1 Detail
Jan 25, 2018 Seed $1.10M 1 Detail

Investors

Number of Lead Investors
Number of Investors
1
2
Flow Neuroscience is funded by 2 investors. SwissHealth Ventures and HAX are the most recent investors.
Investor Name Lead Investor Funding Round
SwissHealth Ventures Yes Series A
HAX Series A